Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors
BioAge Stock Rallies 29% Following Upsized $198M IPO
Oppenheimer points out the next "trend" for weight loss drugs: oral over-the-counter medication.
The competition to develop oral weight-loss drugs is intensifying.
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users
Next Frontier in Anti-obesity Landscape: Oral GLP-1s With Potential OTC Switch
